Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
US5248785A · kind A · utility
8Cited by
7References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 18, 1992 |
| Grant date | Sep 28, 1993 |
| Priority date | — |
| Expiry date | May 18, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A family of compounds has been found to be useful for right-shifting hemoglobin towards a low oxygen affinity state. The compounds are capable of acting on hemoglobin in whole blood. In addition, the compounds can maintain the oxygen affinity in blood during storage and can restore the oxygen affinity of outdated blood.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.